We used siRNAs to knockdown RARRES1 and determine the role of RARRES1 in liver cancer cell proliferation and apoptosis, and the results showed that silencing RARRES1 increased cell viability and cell colony numbers, as well as decreasing the rate of apoptosis and HCC cell sensitivity to lenvatinib. Here, RARRES1 is linked to liver cancer.